How AI is applied across API Evangelist and APIs.io. Read my AI disclosure →
API Evangelist API Evangelist
Discovery
Learnings
Guidance
Toolbox
Alignment
API Evangelist LLC

AASLD 2024: Tune Therapeutics Shows Near-Complete HepB Repression With Tune-401 Epigenetic Silencer

calendar_today November 19, 2024 person Glenn Murphy domain tune-therapeutics

Preclinical data shows strong, durable, and precise repression of HBV DNA acrossin vitro and in vivo models, offering a possible pathway to a functional cure DURHAM, NC and SEATTLE, WA (November 19, 2024) – Leading epigenome editing company Tune Therapeutics showcased new data yesterday at the American Association for the Study of Liver Diseases (AASLD) […]

open_in_new Read original post